pentadecapeptide arginate bpc-157 salt oral stability BPC-157 (Arginate Salt) Gastric pentadecapeptide body protection compound
Description
The community standard isn't a single ratio
Prevention and treatment of nutritional complications after bariatric surgery
A 2025 Phase I trial (Lee & Burgess, 2025) demonstrated that IV BPC-157 doses up to 20 mg were tolerated in healthy volunteers with no serious adverse events
Another commenter suggested that CMS provide greater transparency on the expected discharge function score and/or the imputation method
The injection itself is usually a quick, minor pinch
